By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Orchid Cellmark today reported an 18 percent jump in revenues year over year for the third quarter, led by a boost in its UK business.

For the three months ended Sept. 30, the Princeton N.J.-based DNA testing service firm said revenues totaled $17.3 million, compared to $14.7 million a year ago. In the UK, total revenues increased 44 percent year over year, primarily as a result of a rise in its forensic business there.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.